Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dendritic cell-derived exosomes: A new horizon in personalized cancer immunotherapy?
Ghorbaninezhad F, Alemohammad H, Najafzadeh B, Masoumi J, Shadbad MA, Shahpouri M, Saeedi H, Rahbarfarzam O, Baradaran B. Ghorbaninezhad F, et al. Among authors: masoumi j. Cancer Lett. 2023 May 28;562:216168. doi: 10.1016/j.canlet.2023.216168. Epub 2023 Apr 7. Cancer Lett. 2023. PMID: 37031915 Review.
CTLA-4 silencing in dendritic cells loaded with colorectal cancer cell lysate improves autologous T cell responses in vitro.
Ghorbaninezhad F, Masoumi J, Bakhshivand M, Baghbanzadeh A, Mokhtarzadeh A, Kazemi T, Aghebati-Maleki L, Shotorbani SS, Jafarlou M, Brunetti O, Santarpia M, Baradaran B, Silvestris N. Ghorbaninezhad F, et al. Among authors: masoumi j. Front Immunol. 2022 Aug 1;13:931316. doi: 10.3389/fimmu.2022.931316. eCollection 2022. Front Immunol. 2022. PMID: 35979362 Free PMC article.
STATs signaling pathways in dendritic cells: As potential therapeutic targets?
Sohrabi S, Masoumi J, Naseri B, Ghorbaninezhad F, Alipour S, Kazemi T, Ahmadian Heris J, Aghebati Maleki L, Basirjafar P, Zandvakili R, Doustvandi MA, Baradaran B. Sohrabi S, et al. Among authors: masoumi j. Int Rev Immunol. 2024 May;43(3):138-159. doi: 10.1080/08830185.2023.2274576. Epub 2023 Oct 27. Int Rev Immunol. 2024. PMID: 37886903 Review.
Glyburide-treated human monocyte-derived dendritic cells loaded with insulin represent tolerogenic features with anti-inflammatory responses and modulate autologous T cell responses in vitro.
Alipour S, Kazemi T, Sadeghi MR, Heris JA, Masoumi J, Naseri B, Baghbani E, Sohrabi S, Baradaran B. Alipour S, et al. Among authors: masoumi j. Int Immunopharmacol. 2024 Jan 5;126:111230. doi: 10.1016/j.intimp.2023.111230. Epub 2023 Nov 17. Int Immunopharmacol. 2024. PMID: 37979448
Leptin/lipopolysaccharide-treated dendritic cell vaccine improved cellular immune responses in an animal model of breast cancer.
Basirjafar P, Zandvakili R, Masoumi J, Zainodini N, Taghipour Z, Khorramdelazad H, Yousefi S, Tavakoli T, Vatanparast M, Safdel S, Gheitasi M, Ayoobi F, Naseri B, Jafarzadeh A. Basirjafar P, et al. Among authors: masoumi j. Immunopharmacol Immunotoxicol. 2024 Feb;46(1):73-85. doi: 10.1080/08923973.2023.2253989. Epub 2023 Aug 30. Immunopharmacol Immunotoxicol. 2024. PMID: 37647347
22 results